2026 ICD-10-CM Diagnosis Code D69.3Immune thrombocytopenic purpura
ICD-10-CM Codes›D50–D89›D65-D69›D69
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Risk Adjusts — HCC 112
- Chronic Condition
D69.3 is a billable ICD-10-CM diagnosis code for immune thrombocytopenic purpura. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 813. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 52 closely related codes. Coders also document this condition as chronic hemolytic anemia. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.
For Medicare Advantage risk adjustment, D69.3 maps to CMS-HCC Category 112 (Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions) under the V28 model, adding a risk factor of about 0.450 for a community, non-dual, aged beneficiary in payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
D69.3 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Chronic hemolytic anemia
- Chronic idiopathic thrombocytopenic purpura
- Cyclic thrombocytopenia
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Hemorrhagic (thrombocytopenic) purpura
- Idiopathic thrombocytopenic purpura
- Tidal platelet dysgenesis
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
tidal platelet D69.3
immune thrombocytopenic D69.3
hemorrhagic D69.3
idiopathic D69.3
immune D69.3
Thrombocytopenia, thrombocytopenic D69.6
essential D69.3
idiopathic D69.3
idiopathic D69.3
Werlhof's disease D69.3
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Platelet Disorders
Platelets, also known as thrombocytes, are blood cells. They form in your bone marrow, a sponge-like tissue in your bones. Platelets play a major role in blood clotting. Normally, when one of your blood vessels is injured, you start to bleed.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D69.3 to ICD-9-CMHistory
Code HistoryHistory
Questions About D69.3Overview
What is the ICD-10 code for immune thrombocytopenic purpura?
The ICD-10-CM code for immune thrombocytopenic purpura is D69.3 (sometimes written as D693). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is D69.3 (Purpura and other hemorrhagic conditions) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report immune thrombocytopenic purpura on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D69.3 group to?
When immune thrombocytopenic purpura is the principal diagnosis on an inpatient stay, it groups to MS-DRG 813 (coagulation Disorders), which carries a relative weight of 1.5253. Higher weights mean higher Medicare reimbursement.
Is D69.3 a CC or MCC?
CMS lists D69.3 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 52 closely related codes in its exclusion list.
What is the ICD-9 equivalent of D69.3?
Under the General Equivalence Mappings, immune thrombocytopenic purpura converts to ICD-9-CM 287.31 (immune thrombocyt purpra) and 287.39 (prim thrombocytopen NEC). The mapping is approximate, so confirm the match fits the documentation.
What HCC is D69.3?
D69.3 (immune thrombocytopenic purpura) maps to CMS-HCC Category 112 (Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions), commonly written as HCC 112, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 48 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 100.
Does D69.3 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, D69.3 adds a risk adjustment factor of about 0.450 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.450 to 0.708 depending on the payment segment). A more severe related category (HCC 111) supersedes it when both are reported. See the full factor table on the HCC 112 category page.
